Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • OPTIMER PHARMACEUTICALS INC Financial Overview

  • Income Statement: OPTR

      2008 2007 Change ( 2007 - 2008  )
    Net Sales/Revenues 1.02 M 767,165.00 256,205.00 25.04%
    Gross Profit 803,492.00 481,650.00 321,842.00 40.06%
    Net Income Before Extra Items/Preferred Div -35.58 M -46.14 M 10.55 M -29.66%
    Operating Income -37.15 M -48.20 M 11.05 M -29.76%
  • Cash Flow: OPTR

      2008 2007 Change ( 2007 - 2008  )
    Net Cash Flow - Financing 15.10 M 78.86 M -63.75 M -422.19%
    Net Cash Flow - Investing -31.73 M 40.63 M -72.36 M 228.03%
    Net Cash Flow/Operating Activities -33.27 M -41.18 M 7.91 M -23.79%
  • Balance Sheet: OPTR

      2008 2007 Change ( 2007 - 2008  )
    Total Assets 42.30 M 60.79 M -18.49 M -43.72%
    Total Liabilities 8.06 M 7.88 M 182,924.00 2.27%
    Shareholders Equity 34.23 M 52.90 M -18.67 M -54.55%
  • Key Ratios / Statistics: OPTR

    • Valuation

      Price/Earnings (TTM) -9.77
      Price/Sales (TTM) 339.41
      Price/Book (MRQ) 10.91
      Price/Cash Flow (TTM) -9.51
    • Profitability

      Gross Margin 78.51
      Operating Margin -3,629.82
      Profit Margin -3,477.20
    • Dividends

      Dividend Paid (TTM) 0.00
      Payout Ratio % (TTM) 0.00
    • Financial Strength

      Quick Ratio (MRQ) 5.06
      Current Ratio (MRQ) 5.37
      Long Term Debt-to-Equity (MRQ) 0.00
    • Management Effectiveness

      Return on Equity (TTM) -81.37
      Return on Assets (TTM) -85.20
      Return on Investments (TTM) -81.68